StockData
CV Sciences, Inc. logo

CV Sciences, Inc. (CVSI) stock

CVSIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/30
$0.01−0.00 (-21.13%)

Close on Oct 19, 2026Market cap $2.53MP/E –Yield –

CV Sciences price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

CV Sciences's price to sales ratio was 0.2× on Oct 19, 2026, against 0.4× a year earlier. Over the last 5 years it ranged from 0.2× to 1.1×, with a median of 0.4×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20260.2×−0.6
2025Dec 31, 20250.8×+0.4
2024Dec 31, 20240.4×+0.0
2023Dec 29, 20230.4×+0.1
2022Dec 30, 20220.3×−0.4
2021Dec 31, 20210.7×−1.0
2020Dec 31, 20201.6×+0.0
2019Dec 31, 20191.6×−8.2
2018Dec 31, 20189.9×+6.5
2017Dec 29, 20173.3×+1.1
2016Dec 30, 20162.2×+1.5
2015Dec 31, 20150.7×−8.7
2014Dec 31, 20149.4×−237.8
2013Dec 31, 2013247.2×–

More CV Sciences figures

See a number that looks wrong?